Novel FISH probes designed to detect IGK-MYC and IGL-MYC rearrangements in B-cell lineage malignancy identify a new breakpoint cluster region designated BVR2

Leukemia

Volumn 20, Issue 10, 2006, Pages 1790-1799

  Einerson, R R ^a   Law, M E ^a   Blair, H E ^a   Kurtin, P J ^a   McClure, R F ^a   Ketterling, R P ^a   Flynn, H C ^a   Dogan, A ^a   Remstein, E D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN;

ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; CLUSTER ANALYSIS; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; VALIDATION PROCESS;

EID: 33750036396     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404340     Document Type: Article

References (89)

1. Au WY, Horsman DE, Gascoyne RD, Viswanatha DS, Klasa RJ, Connors JM. The spectrum of lymphoma with 8q24 aberrations: A clinical, pathological and cytogenetic study of 87 consecutive cases. Leuk Lymphoma 2004; 45: 519-528.
2. McClure RF, Remstein ED, Macon WR, Dewald GW, Habermann TM, Hoering A et al. Adult B-cell lymphomas with Burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior. Am J Surg Pathol 2005; 29: 1652-1660.
3. Ladanyi M, Offit K, Chaganti RS. Variant t(8;14) translocations in non-Burkitt's non-Hodgkin's lymphomas. Blood 1992; 79: 1377-1379.
4. Ladanyi M, Offit K, Jhanwar SC, Filippa DA, Chaganti RS. MYC rearrangement and translocations involving band 8q24 in diffuse large cell lymphomas. Blood 1991; 77: 1057-1063.
5. Au WY, Horsman DE, Viswanatha DS, Connors JM, Klasa RJ, Gascoyne RD. 8q24 translocations in blastic transformation of mantle cell lymphoma. Haematologica 2000; 85: 1225-1227.
6. Drach J, Kaufmann H, Urbauer E, Schreiber S, Ackermann J, Huber H. The biology of multiple myeloma. J Cancer Res Clin Oncol 2000; 126: 441-447.
7. Shou Y, Martelli ML, Gabrea A, Qi Y, Brents LA, Roschke A et al. Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma. Proc Natl Acad Sci USA 2000; 97: 228-233.
8. Fabris S, Storlazzi CT, Baldini L, Nobili L, Lombardi L, Maiolo AT et al. Heterogeneous pattern of chromosomal breakpoints involving the MYC locus in multiple myeloma. Genes Chromosomes Cancer 2003; 37: 261-269.
9. Macpherson N, Lesack D, Klasa R, Horsman D, Connors JM, Barnett M et al. Small noncleaved, non-Burkitt's (Burkitt-like) lymphoma: Cytogenetics predict outcome and reflect clinical presentation. J Clin Oncol 1999; 17: 1558-1567.
10. Kanungo A, Medeiros LJ, Abruzzo LV, Lin P. Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis. Mod Pathol 2006; 19: 25-33.
11. Magrath I, Jaffe ES, Bhatia K. Burkitt's lymphoma. In: Knowles DM (ed). Neoplastic Hematopathology, 2nd edn. Lippincott Williams & Wilkins: Philadelphia, PA, 2001, pp 953-986.
12. Bornkamm GW, Polack A, Eick D. c-myc Deregulation by chromosomal translocation in Burkitt's lymphoma. In: Klein G (ed). Cellular Oncogene Activation. Marcel Dekker: New York, NY, 1988, pp 223-273.
13. Cory S. Activation of cellular oncogenes in hematopoietic cells by chromosome translocation. Adv Cancer Res 1986; 47: 189-234.
14. Joos S, Falk MH, Lichter P, Haluska FG, Henglein B, Lenoir GM et al. Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kb. Hum Mol Genet 1992; 1: 625-632.
15. Haralambieva E, Schuuring E, Rosati S, van Noesel C, Jansen P, Appel I et al. Interphase fluorescence in situ hybridization for detection of 8q24/MYC breakpoints on routine histologic sections: Validation in Burkitt lymphomas from three geographic regions. Genes Chromosomes Cancer 2004; 40: 10-18.
16. Cario G, Stadt UZ, Reiter A, Welte K, Sykora KW. Variant translocations in sporadic Burkitt's lymphoma detected in fresh tumour material: analysis of three cases. Br J Haematol 2000; 110: 537-546.
17. Henglein B, Synovzik H, Groitl P, Bornkamm GW, Hartl P, Lipp M. Three breakpoints of variant t(2;8) translocations in Burkitt's lymphoma cells fall within a region 140 kilobases distal from c-myc. Mol Cell Biol 1989; 9: 2105-2113.
18. Henglein B, Lipp M, Hartl P, Adolph S, Hameister H, Eick D et al. Burkitt's lymphoma variant translocations: Distribution of chromosomal breakpoints and perturbated regulation of a mutated c-myc gene. Curr Top Microbiol Immunol 1988; 141: 165-171.
19. Willis TG, Dyer MJ. The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood 2000; 96: 808-822.
20. Poulsen TS, Silahtaroglu AN, Gisselo CG, Tommerup N, Johnsen HE. Detection of illegitimate rearrangements within the immunoglobulin light chain loci in B cell malignancies using end sequenced probes. Leukemia 2002; 16: 2148-2155.
21. Martin-Subero JI, Harder L, Gesk S, Schlegelberger B, Grote W, Martinez-Climent JA et al. Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci. Int J Cancer 2002; 98: 470-474.
22. Law ME, Templeton KL, Kitange G, Smith J, Misra A, Feuerstein BG et al. Molecular cytogenetic analysis of chromosomes 1 and 19 in glioma cell lines. Cancer Genet Cytogenet 2005; 160: 1-14.
23. Einerson RR, Kurtin PJ, Dayharsh GA, Kimlinger TK, Remstein ED. FISH Is superior to PCR in detecting t(14;18)(q32;q21)-IgH/bcl-2 in follicular lymphoma using paraffin-embedded tissue samples. Am J Clin Pathol 2005; 124: 421-429.
24. Cataldo KA, Jalal SM, Law ME, Ansell SM, Inwards DJ, Fine M et al. Detection of t(2;5) in anaplastic large cell lymphoma: Comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue. Am J Surg Pathol 1999; 23: 1386-1392.
25. Bornkamm GW, Kaduk B, Kachel G, Schneider U, Fresen KO, Schwanitz G et al. Epstein-Barr virus-positive Burkitt's lymphoma in a German woman during pregnancy. Blut 1980; 40: 167-177.
26. Bernheim A, Berger R, Lenoir G. Cytogenetic studies on African Burkitt's lymphoma cell lines: T(8;14), t(2;8) and t(8;22) translocations. Cancer Genet Cytogenet 1981; 3: 307-315.
27. Bernheim A, Berger R, Lenoir G. Cytogenetic studies on Burkitt's lymphoma cell lines. Cancer Genet Cytogenet 1983; 8: 223-229.
28. Lenoir GM, Vuillaume M, Bonnardel C. The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma. In: Lenoir GM, O'Conor GT, Olweny CLM (eds). Burkitt's Lymphoma: A Human Cancer Model. International Agency for Research on Cancer: Lyon, 1985, pp 309-318.
29. Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. World Health Organization: Lyon, 2001, pp 111-114, 142-145, 171-174, 181-184.
30. Dewald GW, Broderick DJ, Tom WW, Hagstrom JE, Pierre RV. The efficacy of direct, 24-hour culture, and mitotic synchronization methods for cytogenetic analysis of bone marrow in neoplastic hematologic disorders. Cancer Genet Cytogenet 1985; 18: 1-10.
31. Mitelman F (ed). An International System for Human Cytogenetic Nomenclature. Basel: Karger, 1995, pp 5-85.
32. Rack KA, Delabesse E, Radford-Weiss I, Bourquelot P, Le Guyader G, Vekemans M et al. Simultaneous detection of MYC, BVR1, and PVT1 translocations in lymphoid malignancies by fluorescence in situ hybridization. Genes Chromosomes Cancer 1998; 23: 220-226.
33. Haralambieva E, Banham AH, Bastard C, Delsol G, Gaulard P, Ott G et al. Detection by the fluorescence in situ hybridization technique of MYC translocations in paraffin-embedded lymphoma biopsy samples. Br J Haematol 2003; 121: 49-56.
34. Siebert R, Matthiesen P, Harder S, Zhang Y, Borowski A, Zuhlke-Jenisch R et al. Application of interphase fluorescence in situ hybridization for the detection of the Burkitt translocation t(8;14)(q24;q32) in B-cell lymphomas. Blood 1998; 91: 984-990.
35. Barth TF, Muller S, Pawlita M, Siebert R, Rother JU, Mechtersheimer G et al. Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with MYC rearrangement. J Pathol 2004; 203: 940-945.
36. Veronese ML, Ohta M, Finan J, Nowell PC, Croce CM. Detection of myc translocations in lymphoma cells by fluorescence in situ hybridization with yeast artificial chromosomes. Blood 1995; 85: 2132-2138.
37. Levine EG, Arthur DC, Machnicki J, Frizzera G, Hurd D, Peterson B et al. Four new recurring translocations in non-Hodgkin lymphoma. Blood 1989; 74 (5): 1796-1800.
38. Smadja NV, Fru, Isnard F, Louvet C, Dutel JL, Cheron N et al. Chromosomal analysis in multiple myeloma: Cytogenetic evidence of two different diseases. Leukemia 1998; 12: 960-969.
39. Seong C, Delasalle K, Hayes K, Weber D, Dimopoulos M, Swantkowski J et al. Prognostic value of cytogenetics in multiple myeloma. Br J Haematol 1998; 101: 189-194.
40. Au WY, Gascoyne RD, Viswanatha DS, Connors JM, Klasa RJ, Horsman DE. Cytogenetic analysis in mantle cell lymphoma: A review of 214 cases. Leuk Lymphoma 2002; 43: 783-791.
41. Dunphy CH, van Deventer HW, Carder KJ, Rao KW, Dent GA. Mature B-cell acute lymphoblastic leukemia with associated translocations (14;18)(q32;q21) and (8;9)(q24;p13). A Burkitt variant? Arch Pathol Lab Med 2003; 127: 610-613.
42. Pantou D, Rizou H, Tsarouha H, Pouli A, Papanastasiou K, Stamatellou M et al. Cytogenetic manifestations of multiple myeloma heterogeneity. Genes Chromosomes Cancer 2005; 42: 44-57.
43. Sawyer JR, Lukacs JL, Munshi N, Desikan KR, Singhal S, Mehta J et al. Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping. Blood 1998; 92: 4269-4278.
44. Sawyer JR, Lukacs JL, Thomas EL, Swanson CM, Goosen LS, Sammartino G et al. Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma. Br J Haematol 2001; 112: 167-174.
45. Avet-Loiseau H, Daviet A, Brigaudeau C, Callet-Bauchu E, Terre C, Lafage-Pochitaloff M et al. Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: A study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myelome and the Groupe Francais de Cytogenetique Hematologique. Blood 2001; 97: 822-825.
46. Avet-Loiseau H, Gerson F, Magrangeas F, Minvielle S, Harousseau JL, Bataille R. Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors. Blood 2001; 98: 3082-3086.
47. McKeithan TW, Shima EA, Le Beau MM, Minowada J, Rowley JD, Diaz MO. Molecular cloning of the breakpoint junction of a human chromosomal 8;14 translocation involving the T-cell receptor alpha-chain gene and sequences on the 3′ side of MYC. Proc Natl Acad Sci USA 1986; 83: 6636-6640.
48. Shima EA, Le Beau MM, McKeithan TW, Minowada J, Showe LC, Mak TW et al. Gene encoding the alpha chain of the T-cell receptor is moved immediately downstream of c-myc in a chromosomal 8;14 translocation in a cell line from a human Tcell leukemia. Proc Natl Acad Sci USA 1986; 83: 3439-3443.
49. Finver SN, Nishikura K, Finger LR, Haluska FG, Finan J, Nowell PC et al. Sequence analysis of the MYC oncogene involved in the t(8;14)(q24;q11) chromosome translocation in a human leukemia T-cell line indicates that putative regulatory regions are not altered. Proc Natl Acad Sci USA 1988; 85: 3052-3056.
50. Bernard O, Larsen CJ, Hampe A, Mauchauffe M, Berger R, Mathieu-Mahul D. Molecular mechanisms of a t(8;14)(q24;q11) translocation juxtaposing c-myc and TcR-alpha genes in a T-cell leukaemia: Involvement of a V alpha internal heptamer. Oncogene 1988; 2: 195-200.
51. Park JK, McKeithan TW, Le Beau MM, Bitter MA, Franklin WA, Rowley JD et al. An (8;14)(q24;q11) translocation involving the Tcell receptor alpha-chain gene and the MYC oncogene 3′ region in a B-cell lymphoma. Genes Chromosomes Cancer 1989; 1: 15-22.
52. O'Connor R, Cesano A, Kreider BL, Lange B, Clark SC, Nowell PC et al. Growth factor-dependent differentiation along the myeloid and lymphoid lineages in an immature acute T lymphocytic leukemia. J Immunol 1990; 145: 3779-3787.
53. Rimokh R, Rouault JP, Wahbi K, Gadoux M, Lafage M, Archimbaud E et al. A chromosome 12 coding region is juxtaposed to the MYC protooncogene locus in a t(8;12)(q24;q22) translocation in a case of B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer 1991; 3: 24-36.
54. Finger LR, Huebner K, Cannizzaro LA, McLeod K, Nowell PC, Croce CM. Chromosomal translocation in T-cell leukemia line HUT 78 results in a MYC fusion transcript. Proc Natl Acad Sci USA 1988; 85: 9158-9162.
55. Manolov G, Manolova Y, Klein G, Lenoir G, Levan A. Alternative involvement of two cytogenetically distinguishable breakpoints on chromosome 8 in Burkitt's lymphoma associated translocations. Cancer Genet Cytogenet 1986; 20: 95-99.
56. Zeidler R, Joos S, Delecluse HJ, Klobeck G, Vuillaume M, Lenoir GM et al. Breakpoints of Burkitt's lymphoma t(8;22) translocations map within a distance of 300 kb downstream of MYC. Genes Chromosomes Cancer 1994; 9: 282-287.
57. Ratsch A, Joos S, Kioschis P, Lichter P. Topological organization of the MYC/IGK locus in Burkitt's lymphoma cells assessed by nuclear halo preparations. Exp Cell Res 2002; 273: 12-20.
58. Nishida K, Ritterbach J, Repp R, Harbott J, Lampert F. Characterization of chromosome 8 abnormalities by fluorescence in situ hybridization in childhood B-acute lymphoblastic leukemia/non-Hodgkin lymphoma. Cancer Genet Cytogenet 1995; 79: 8-14.
59. ar-Rushdi A, Nishikura K, Erikson J, Watt R, Rovera G, Croce CM. Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma. Science 1983; 222: 390-393.
60. Nishikura K, ar-Rushdi A, Erikson J, Watt R, Rovera G, Croce CM. Differential expression of the normal and of the translocated human c-myc oncogenes in B cells. Proc Natl Acad Sci USA 1983; 80: 4822-4826.
61. Erikson J, Nishikura K, ar-Rushdi A, Finan J, Emanuel B, Lenoir G et al. Translocation of an immunoglobulin kappa locus to a region 3′ of an unrearranged c-myc oncogene enhances c-myc transcription. Proc Natl Acad Sci USA 1983; 80: 7581-7585.
62. Croce CM, Thierfelder W, Erikson J, Nishikura K, Finan J, Lenoir GM et al. Transcriptional activation of an unrearranged and untranslocated c-myc oncogene by translocation of a C lambda locus in Burkitt. Proc Natl Acad Sci USA 1983; 80: 6922-6926.
63. Taub R, Kelly K, Battey J, Latt S, Lenoir GM, Tantravahi U et al. A novel alteration in the structure of an activated c-myc gene in a variant t(2;8) Burkitt lymphoma. Cell 1984; 37: 511-520.
64. Ptashne M. Gene regulation by proteins acting nearby and at a distance. Nature 1986; 322: 697-701.
65. Mueller-Storm HP, Sogo JM, Schaffner W. An enhancer stimulates transcription in trans when attached to the promoter via a protein bridge. Cell 1989; 58: 767-777.
66. Fourel G, Couturier J, Wei Y, Apiou F, Tiollais P, Buendia MA. Evidence for long-range oncogene activation by hepadnavirus insertion. EMBO J 1994; 13: 2526-2534.
67. Cullen KE, Kladde MP, Seyfred MA. Interaction between transcription regulatory regions of prolactin chromatin. Science 1993; 261: 203-206.
68. Sasaki H, Ishihara K, Kato R. Mechanisms of Igf2/H19 imprinting: DNA methylation, chromatin and long-distance gene regulation. J Biochem (Tokyo) 2000; 127: 711-715.
69. Wittekindt NE, Hortnagel K, Geltinger C, Polack A. Activation of c-myc promoter P1 by immunoglobulin kappa gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs kappaB, E box 1 and E box 2, and of the 30 enhancer motif PU. Nucleic Acids Res 2000; 28: 800-808.
70. Spencer CA, Groudine M. Control of c-myc regulation in normal and neoplastic cells. Adv Cancer Res 1991; 56: 1-48.
71. Polack A, Feederle R, Klobeck G, Hortnagel K. Regulatory elements in the immunoglobulin kappa locus induce c-myc activation and the promoter shift in Burkitt's lymphoma cells. EMBO J 1993; 12: 3913-3920.
72. Hortnagel K, Mautner J, Strobl LJ, Wolf DA, Christoph B, Geltinger C et al. The role of immunoglobulin kappa elements in c-myc activation. Oncogene 1995; 10: 1393-1401.
73. Geltinger C, Hortnagel K, Polack A. TATA box and Sp1 sites mediate the activation of c-myc promoter P1 by immunoglobulin kappa enhancers. Gene Expr 1996; 6: 113-127.
74. Mautner J, Behrends U, Hortnagel K, Brielmeier M, Hammerschmidt W, Strobl L et al. c-myc expression is activated by the immunoglobulin kappa-enhancers from a distance of at least 30 kb but not by elements located within 50 kb of the unaltered c-myc locus in vivo. Oncogene 1996; 12: 1299-1307.
75. Gerbitz A, Mautner J, Geltinger C, Hortnagel K, Christoph B, Asenbauer H et al. Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma. Oncogene 1999; 18: 1745-1753.
76. Cockerill PN, Garrard WT. Chromosomal loop anchorage sites appear to be evolutionarily conserved. FEBS Lett 1986; 204: 5-7.
77. Cockerill PN, Garrard WT. Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites. Cell 1986; 44: 273-282.
78. Asenbauer H, Combriato G, Klobeck HG. The immunoglobulin lambda light chain enhancer consists of three modules which synergize in activation of transcription. Eur J Immunol 1999; 29: 713-724.
79. Blomberg BB, Rudin CM, Storb U. Identification and localization of an enhancer for the human lambda L chain Ig gene complex. J Immunol 1991; 147: 2354-2358.
80. Lefranc MP. Nomenclature of the human immunoglobulin kappa (IGK) genes. Exp Clin Immunogenet 2001; 18: 161-174.
81. Kawasaki K, Minoshima S, Nakato E, Shibuya K, Shintani A, Asakawa S et al. Evolutionary dynamics of the human immunoglobulin kappa locus and the germline repertoire of the Vkappa genes. Eur J Immunol 2001; 31: 1017-1028.
82. Zachau HG. The human immunoglobulin K genes. In: Honjo T, Alt FW (eds). Immunoglobulin Genes. 2nd edn. Academic Press: San Diego, CA, 1995, pp 173-191.
83. Whitehurst C, Henney HR, Max EE, Schroeder Jr HW, Stuber F, Siminovitch KA et al. Nucleotide sequence of the intron of the germline human kappa immunoglobulin gene connecting the J and C regions reveals a matrix association region (MAR) next to the enhancer. Nucleic Acids Res 1992; 20: 4929-4930.
84. Gimble JM, Max EE. Human immunoglobulin kappa gene enhancer: Chromatin structure analysis at high resolution. Mol Cell Biol 1987; 7: 15-25.
85. Judde JG, Max EE. Characterization of the human immunoglobulin kappa gene 30 enhancer: Functional importance of three motifs that demonstrate B-cell-specific in vivo footprints. Mol Cell Biol 1992; 12: 5206-5216.
86. Klobeck HG, Zachau HG. The human CK gene segment and the kappa deleting element are closely linked. Nucleic Acids Res 1986; 14: 4591-4603.
87. Lefranc MP. Nomenclature of the human immunoglobulin lambda (IGL) genes. Exp Clin Immunogenet 2001; 18: 242-254.
88. Kawasaki K, Minoshima S, Nakato E, Shibuya K, Shintani A, Schmeits JL et al. One-megabase sequence analysis of the human immunoglobulin lambda gene locus. Genome Res 1997; 7: 250-261.
89. Kawasaki K, Minoshima S, Schooler K, Kudoh J, Asakawa S, de Jong PJ et al. The organization of the human immunoglobulin lambda gene locus. Genome Res 1995; 5: 125-135.